Obermatt
See Similar Stocks →

Beyondspring

NAQ:BYSI · KYG108301006
BiotechnologyX-Small

360° View

no current rank
Price/Sales—
Price/Earnings—
Price/Book90
Dividend Yield—
Revenue Growth—
Profit Growth5
Capital Growth18
TSR 52w24
Leverage20
Liquidity77
Refinancing20
Combined—
Analyst Opinions—
Pro Holdings9
Opinion Changes—
Market Pulse3

Profile

CountryUSA
IndustryBiotechnology
SizeX-Small
TypePublic Company
ExchangeNASDAQCM
Founded2014
Employees14
Websitebeyondspringpharma.com/en
ISINKYG108301006
Last UpdateApr 2, 2026
Index & Theme
HematologyImmunologyCentral Nervous SystemOncologyBiopharmaHealth CarePharmaceuticalTherapeutics

Description

BeyondSpring Inc. operates as a clinical-stage biopharmaceutical company. The company focuses on developing innovative therapies to improve clinical outcomes for patients with high unmet medical needs. The company's first-in-class lead asset, Plinab…

Similar Stocks

The companies this stock is ranked against.

Compare Beyondspring with its peers
Sellas Life Sciences
NAQ:SLS
62
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Cartesian Therapeutics
NMQ:RNAC
20
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
AnaptysBio
NSQ:ANAB
44
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Nuvalent
NSQ:NUVL
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Actuate Therapeutics
NMQ:ACTU
—
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
CytomX Therapeutics
NSQ:CTMX
8
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →